Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz — Clinical Trial Site

51 Registered trials

13 Currently recruiting

Organisation

Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz

Location

Szombathely, Hungary

Identifier

ORG-100031713

Address

Markusovszky Str. 5, 9700, Hungary

Departments

1904:Szemészeti Osztály
2203 : Kardiológiai Osztály
3305: Tudogondozo
3480023: Szemészeti Osztály
348004
93129002: Onkoradiológiai Osztály
Borgyogyaszati Osztaly
Cardiology
Department of Hematology
Dermatology
Diabetológiai Szakrendelés
Gasztroenterologiai es Belgyogyaszati Osztaly
Haematologiai es Haemosztazeologiai Osztaly
Hematology Department
HU10005:Gasztroenterológiai és Belgyógyászati Osztály
HU10007: Gasztroenterológiai és Belgyógyászati Osztály
Intensive Care Unit
Kardiologiai es Belgyogyaszati Osztaly
Központi Aneszteziológiai és Intenzív Betegellátó Osztály
N/A
Nephrologia Szakambulancia
Oktatókórház Onkoradiológia
Onkoradiológiai Osztály
Ophthalmology
Szemészeti Osztály
Tüdőgondozó
Tudogondozo es Tudoszuro
Tüdőgyógyászat
Tudogyogyaszati Osztaly
Vas Vármegyei Markusovszky Egyetemi Oktatókórház, Gasztroenterológiai és Belgyógyászati Osztály

Clinical trials at this site (51)

Search interface

Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Crohn's Disease Ended

2023-504741-32-00 Moderately to Severely Active Crohn's Disease 4 2022-11-30
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Ulcerative Colit… Ended

2023-504743-13-00 Moderately to Severely Active Ulcerative Colitis 4 2022-11-30
SC versus IV isatuximab in combination with pomalidomide and dexamethasone in RRMM Ended

2023-508869-32-00 Cancer - Plasma cell myeloma recurrent 5 2022-11-10
This study is to find out about the Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in… Ended

2023-505628-67-00 Relapsed and Refractory Follicular Lymphoma 5 2022-10-28
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients with Uncontrolled Moderate to Sev… Ended

2024-513423-16-00 Asthma 6 2022-08-25
An Open-label, Randomized Phase 3 Study of Immune and Targeted Combination Therapies, as First-line Treatment in Participants with Advanced … Ended

2022-502122-41-00 Clear cell renal cancer 5 2021-05-11
A phase III multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant trea… Ended

2023-510357-42-00 hormone receptor (HR)-positive, HER2-negative, early br 5 2019-05-22
Long Term Safety and Efficacy of ABT-494 in Subjects with Ulcerative Colitis. Ended

2023-505699-31-00 Ulcerative Colitis 5 2017-01-02
A study of efgartigimod PH20 SC given by prefilled syringe in adults with thyroid eye disease Ended

2023-509197-35-00 Thyroid Eye Disease (TED) 5 2024-10-17
A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 With a Randomized Withdrawal and Retreatment Period in Subject… Ended

2023-505842-24-00 Moderate to Severe Plaque Psoriasis 5 2024-05-07
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
REIMAGINE 2: A research study to see how well CagriSema compared to semaglutide, cagrilintide and placebo lowers blood sugar and body weight… Ended

2022-502678-18-00 Type 2 diabetes 5 2023-11-07
A trial to evaluate the efficacy and safety of different doses of LEO 138559 in adults with moderate-to-severe atopic dermatitis. Ended

2022-500777-14-00 Atopic Dermatitis 4 2023-11-06
A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of Atuliflapon Given Orally Once Daily for Twel… Ended

2023-509243-27-00 Moderate-to-Severe Uncontrolled Asthma 4 2023-04-12
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68) Ended

2024-517612-29-00 acute heart failure 11 2023-02-14
Dose ranging study of amlitelimab in adult participants with moderate-to-severe asthma Ended

2024-510641-33-00 Asthma 4 2023-01-17
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
A Phase 2/3 Double-masked, Randomized, 2-stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic M… Ended

2023-507208-30-00 Diabetic Macular Edema (DME) 10 2022-09-20
A study comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF5993 With the Fixed Dose Dual Combination CHF153… Ended

2023-510172-31-00 Chronic obstructive pulmonary disease (COPD) 5 2022-04-22
A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of IV FDY-5301 in patients with a myocardial infarction (STEMI) Ended

2024-514372-40-00 Anterior ST-Elevation Myocardial Infarction 5 2022-04-12
A clinical study to investigate if the investigational drug Diamyd is safe and can preserve insulin production and secretion in adolescents … Ended

2024-513304-33-00 Type 1 diabetes mellitus 5 2022-03-17
A trial to learn how well finerenone works and how safe it is in adult participants with non-diabetic chronic kidney disease Ended

2023-506897-11-00 Non-diabetic chronic kidney disease 5 2021-10-18
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy Ended

2023-510174-13-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2021-06-17
The efficacy and the safety of two doses of CHF6001 for the treatment of Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-510175-60-00 Chronic obstructive pulmonary disease (COPD) and Chron 5 2021-06-16